Market Overview - Investors face a dilemma of holding stocks or cash during the upcoming National Day holiday, as A-shares will be closed while overseas markets remain open [1] - Historical data indicates a "post-holiday effect" in the A-share market, with a higher probability of a "post-holiday opening red" [1][2] - Over the past decade, the Shanghai Composite Index has generally performed better after holidays compared to before, with post-holiday gains often being more sustained during significant market rallies [1] A-share Performance Data - The table shows the performance of the Shanghai Composite Index before and after the National Day holiday from 2015 to 2024, highlighting the percentage changes [2] - The probability of the index rising post-holiday is 70% for the first trading day and 60% for the first five trading days [2] Hong Kong Market Insights - The Hong Kong market exhibits a "mid-holiday effect," with a tendency to rise during the National Day holiday, although the first trading day after the holiday may be weaker [5] - The Hang Seng Technology Index shows a higher probability of rising post-holiday, especially when the market is in an upward trend [5][6] Sector Performance Expectations - In the A-share market, sectors such as computer, beauty care, environmental protection, pharmaceutical biology, and automotive are expected to show strong performance in the five trading days following the holiday [8] - For the Hong Kong market, all sectors except comprehensive finance have an upward probability of over 60%, with consumer, high-beta, and growth sectors performing relatively well during the holiday [8][9] Investment Strategies - The report suggests focusing on "hard technology" sectors, including technology, chips, computing power, robotics, and artificial intelligence, as they are expected to lead market trends [11][13] - The "anti-involution" theme is highlighted, particularly in the battery and non-ferrous metals sectors, which are anticipated to benefit from policy catalysts and demand [13] - The report also emphasizes the potential of innovative pharmaceuticals, particularly in the Hong Kong market, due to favorable liquidity conditions and low valuations [14] Broader Market Trends - The report indicates that broad-based ETFs are likely to capture market trends effectively, with financial sectors such as brokerage firms expected to lead the charge [11] - The consumer sector is also highlighted as a key area of interest, especially during the holiday season, with significant inflows into consumer-focused ETFs [14]

周五（9月26日），A股震荡调整，沪指跌0.65%，深成指跌1.76%，创业板指低开低走跌2.60%。两市缩 量成交2.15万亿元，全市场超3400只个股下跌。市场热点较为杂乱，以地产、白酒、银行为代表的"老 登"板块逆市活跃，以AI算力、半导体、机器人等为代表的"小登"板块回调。 地产逆市表现，聚焦龙头房企的地产ETF（159707）场内逆市涨逾1%创年内新高，资金抢筹2350万 份；百亿银行ETF（512800）场内逆市收涨，资金近10日加码超10亿元；临近十一长假，食品ETF （515710）全天溢价活跃，或有资金提前埋伏布局； | 序号 代码 类型 名称 | 涨跌幅 ▼ 成交额 | | --- | --- | | 1 159707 · 行 地产ETF | 1.15% 7970.43万 | | 159220 2 | | | 3 516020 主 化工ETF | 0.55% 8913.69万 | | ব 512800 行 银行ETF | 0.13% 9.96亿 | | 5 159296 | 0.10% 359.27万 | 下跌方面，人工智能、金融科技等高人气板块回调，资金逢跌抢筹。连涨五日后，重点布局光模 ...

Market Overview - A-shares experienced fluctuations with the Shanghai Composite Index down 0.65%, Shenzhen Component Index down 1.76%, and ChiNext Index down 2.60, indicating a broad market decline with over 3,400 stocks falling [1] - The total trading volume across both markets was 2.15 trillion yuan, reflecting a decrease in market activity [1] Sector Performance - The real estate sector showed resilience, with the real estate ETF (159707) rising over 1%, reaching a new high for the year, and attracting significant investment with 23.5 million shares purchased [1][3] - The banking ETF (512800) also saw a slight increase, with nearly 1 billion yuan invested over the past ten days [1] - In contrast, high-profile sectors such as AI and fintech experienced pullbacks, with the AI-focused ETF (159363) declining over 3% despite a net subscription of 144 million yuan [1][2] Real Estate Insights - The implementation of new housing policies in Shanghai has led to a significant increase in new home transactions, with a 30% week-on-week rise in the first week and a 19% increase in total transactions for the month [5] - Analysts suggest that the easing of policies in major cities could lead to a short-term recovery in the housing market, with a focus on high-quality developers and those benefiting from debt relief and improved sales [5][6] Food and Beverage Sector - The food and beverage sector, represented by the food ETF (515710), showed mixed performance, with a slight decline of 0.16% [8] - Despite the overall downturn, there are indications of strong sales growth for premium products like Moutai, with sales volume reportedly doubling month-on-month and over 20% year-on-year [11][12] Hong Kong Market Dynamics - The Hong Kong market faced declines, particularly in the internet and innovative drug sectors, with the internet ETF (513770) down 2.6% and the innovative drug ETF (520880) down 1.44% [2][15] - The market's performance is influenced by external factors, including potential tariffs on pharmaceutical products announced by the U.S., which have affected investor sentiment [18][19] Future Outlook - Analysts maintain a positive medium-term outlook for the market, emphasizing the importance of liquidity and the potential for a rebound post-holiday [2][6] - The real estate sector is expected to benefit from seasonal demand during the "Golden September and Silver October" period, with recommendations to focus on leading developers and those with strong land acquisition strategies [5][6]

Core Viewpoint - The A-share market is experiencing a bullish trend, with significant inflows into stock ETFs, particularly in the semiconductor and A500 sectors, indicating a growing investor confidence and potential investment opportunities [3][5][12]. ETF Market Overview - On September 25, the A-share market saw all major indices rise, with the ChiNext Index increasing by over 2%. Stock ETFs experienced a net inflow of over 7 billion yuan, highlighting a shift in investor focus towards specific sectors [3][5]. - The total market size of stock ETFs reached 4.47 trillion yuan as of September 25, with a notable net inflow of 7 billion yuan on that day [5]. - Industry-themed ETFs saw a net inflow of 4.33 billion yuan, with semiconductor-related products attracting the most attention, drawing in 3.27 billion yuan [6]. Sector-Specific Inflows - The A500 ETF from Huatai-PineBridge and the A500 ETF from Fortune both saw significant inflows of 1.12 billion yuan and 993 million yuan, respectively, indicating strong investor interest in these funds [7]. - The semiconductor ETF attracted 710 million yuan, while the coal ETF and robotics ETF saw inflows of 628 million yuan and 555 million yuan, respectively [8]. - Conversely, the CSI 300 Index ETF experienced a net outflow of 1.13 billion yuan, indicating a shift away from broader market indices [10][11]. Future Outlook - According to fund managers, the domestic economic growth momentum is expected to stabilize and improve, supported by favorable industrial policies and increased R&D investments. This environment is likely to enhance the innovation capabilities and global competitiveness of China's advantageous industries [12].

港股医药股走弱，百济神州、信达生物、药明生物、三生制药等跌超3%。 | 代码 | និងកា | 名称 | 现价 | 涨跌 | 涨跌幅 ▲ | | --- | --- | --- | --- | --- | --- | | 159506 | 最 | 港股通医疗日 富国 T+0 | 1.590 | -0.045 | -2.75% | | 159570 | 障 | 港股通创新药ETF T+0 | 1.881 | -0.054 | -2.79% | | 159217 | 覧 | 港股通创新药ETF工银 T+0 | 1.533 | -0.044 | -2.79% | | 513780 | 匿 | 港股创新药50ETF T+0 | 1.885 | -0.050 | -2.58% | | 520690 | 篇 | 港股创新药精选ETF | 0.992 | -0.025 | -2.46% | | 520700 | 腰 | 港股创新药ETF基金 T+0 | 1.818 | -0.047 | -2.52% | | 159615 | 跨 | 恒生生物科技ETF T+0 | 1.324 | -0.034 | -2.50% | | ...

拉长时间看，该基金近2天杠杆资金加速流入，合计流入1420.72万元，居可比基金首位。 港股通创新药ETF（159570.SZ），场外联接(A类：021030；C类：021031）。 2025年9月24日，港股通创新药ETF（159570.SZ）收跌0.47%，成交17.82亿元。获融资买入7010.85万 元，融资偿还5998.89万元，融资净买入1011.96万元，居可比基金第一。 ...

连续5日调整后，港股通创新药板块今日（9月22日）迎来反弹！100%创新药研发标的——港股通创新 药ETF（520880）高开后一度上探2.57%，全天红盘震荡，尾盘二次发力，场内收涨1.77%收复5日均 线，全天成交3.31亿元。 37只成份股涨跌参半，MIRXES-B暴涨27.68%居首，权重股信达生物涨2.88%，康方生物、三生制药涨 超1%。下跌方面，乐普生物-B、君实生物分别跌5.1%、4.67%居前。 港股通创新药ETF（520880）资金面有所印证，数据显示，截至9月19日，520880已连续14日吸金，金 额合计近6.8亿元。 消息面重点关注"第十一批国家组织药品集中采购文件发布"。9月20日，国家医保局发布第十一批国家 组织药品集中采购文件。本次集采方案制定和修改过程中，充分遵循了"稳临床、保质量、防围标、反 内卷"的原则。 对此，港股通创新药ETF（520880）基金经理丰晨成解读认为，第十一批药品集采文件明确要求企业承 诺不低于成本报价，要求保证质量并"反内卷"；在具体政策上也进行了优化，不再"唯低价论"。这是从 近期港股通创新药行情波动加大，低吸机遇凸显，兴证全球策略首席张忆东日前提示 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 基金·研究院 Fund A8 5万亿ETF高歌猛进 同质化背后暗藏 【相关阅读】 应加强监督ETF成份股调整 【5万亿市场高歌猛进！这些隐忧不可轻忽】ETF发展势头迅猛，规模呈爆发式增长，继2024年突破3万 亿元整数关口后，今年又接连迈过4万亿元、5万亿元两大里程碑，扩容速度备受瞩目。值得警惕的是， 耀眼的数字背后，隐忧正逐渐显现。近期市场中接连出现ETF成份股股价大幅震荡、指数成份股流动性 不足、同质化产品扎堆扩容、高波动产品风险评级与实际风险不匹配等现象，再度引发业内广泛关注。 尽管这些问题看似是行业高速扩张中的"小插曲"，但背后暗藏的"隐秘角落"与潜在风险绝不可轻视， 也折射出当前ETF生态建设在关键细节、风险管控等方面存在短板，亟待进一步完善与优化。 ES 215 12 ETF发展势头迅猛，规模呈爆发式增长，继2024年突破3万亿元整数关口后，今年又接连迈过4万亿元、 5万亿元两大里程碑，扩容速度备受瞩目。 值得警惕的是，耀眼的数字背后，隐忧正逐渐显现。近期市场中接连出现ETF成份股股价大幅震荡、指 数成份股流动性不足、同质化产品扎堆扩容、高波动产品 ...

药捷安康近期股价走势 本报（chinatimes.net.cn）记者栗鹏菲 叶青 北京报道 一场围绕创新药企药捷安康的资本狂欢，在经历9月16日的"惊天"震荡后余波未平。截至2025年9月18日 收盘，药捷安康-B（2617.HK）的股价为183.2港元，当日跌幅为12.43%，较9月16日历史高点下跌超 70%，市值维持在727.12亿港元左右。 受药捷安康股价剧烈波动影响，作为跟踪国证港股通创新药指数的代表性产品，港股通创新药ETF （520880）在2025年9月15日至9月17日期间，连续三个交易日净值下跌，累计跌幅为2.4%。跟踪恒生 创新药指数的恒生创新药ETF（520500），同样累计跌幅为2.41%。 药捷安康股价异动的导火索，源于一则临床进展公告。9月10日，公司宣布核心产品替恩戈替尼联合疗 法获国家药监局临床默示许可。尽管消息面利好，公司基本面却未发生实质改变：截至今年6月末，公 司尚无药品上市销售，上半年营收为零，净亏损1.23亿元。在缺乏业绩支撑的背景下，其股价被资金迅 速推高后又急速回落，凸显出创新药领域投资的高风险特性。 资金推动下的估值泡沫：流通盘成炒作温床 药捷安康是一只典型的 ...

Group 1 - The core point of the article is the dramatic price fluctuation of the stock "药捷安康-B" after being included in the Hong Kong Stock Connect and index constituent stocks, leading to significant trading volume and volatility [1][3][12] - From September 8 to September 16, the stock price surged nearly 10 times, reaching a peak of 679.5 HKD, which is a 50-fold increase from its IPO price of 13.15 HKD [1][3] - On September 16, the stock experienced a massive drop of 53.73% after a peak increase of 63.73%, highlighting the volatility and risks associated with small-cap stocks in index funds [1][8] Group 2 - Prior to September 8, "药捷安康-B" was a typical small-cap stock with an average daily trading volume of only 16 million HKD, and it had incurred losses of 343 million CNY in 2023 [3][5] - After being included in the Hong Kong Stock Connect, the stock saw a significant influx of capital, with the number of shares held by the Hong Kong Stock Connect increasing from 96,000 to 409,950 shares by September 16, representing 74.67% of the actual circulating shares [5][6] - The stock's price increase was driven by passive funds that needed to adjust their holdings in response to its inclusion in the index, leading to a feedback loop of rising prices and increased demand [7][8] Group 3 - The article discusses the broader trend of index investing, which has gained popularity due to its low cost and transparency compared to active management, with the total net asset value of stock ETFs in Hong Kong reaching 3.53 trillion HKD by September 16 [12][13] - The rapid growth of index funds has been supported by the increasing difficulty for active funds to outperform the market, leading to a shift in investor preference towards ETFs [17][18] - The expansion of index funds is expected to enhance market pricing efficiency and reduce irrational volatility, although it may also lead to concentration in index-weighted stocks, impacting liquidity for other stocks [27][28]